DSGN EBITDA
Design Therapeutics Inc · EBITDA
DSGN EBITDA
Latest reported-$72.19Mperiod ending
DSGN EBITDA (-$139.00K → -$72.19M)
Annual EBITDA
High-resolution chart · PNG
DSGN ebitda history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA (USD) |
|---|---|
| -69,170,000 | |
| -48,992,000 | |
| -66,325,000 | |
| -62,902,000 | |
| -35,404,000 | |
| -8,275,000 | |
| -139,000 |